Philadelphia Trust CO Abb Vie Inc. Transaction History

Philadelphia Trust CO

$1.38 Billion
Q3 2024

A detailed history of Philadelphia Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Philadelphia Trust CO holds 207,765 shares of ABBV stock, worth $36.4 Million. This represents 2.98% of its overall portfolio holdings.

Number of Shares

207,765

Previous 207,063 0.34%

Holding current value

$36.4 Million

Previous $35.5 Million 15.53%

% of portfolio

2.98%

Previous 2.76%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $115,015 - $139,929	702 Added 0.34%	207,765 $41 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $213,455 - $249,268	1,379 Added 0.67%	207,063 $35.5 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $2.01 Million - $2.29 Million	12,597 Added 6.52%	205,684 $37.5 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $315,104 - $354,881	-2,290 Reduced 1.17%	193,087 $29.9 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $1.39 Million - $1.61 Million	-10,426 Reduced 5.07%	195,377 $29.1 Million
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $598,945 - $745,348	-4,520 Reduced 2.15%	205,803 $27.7 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $2.29 Million - $2.64 Million	-15,858 Reduced 7.01%	210,323 $33.5 Million
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $2.95 Million - $3.53 Million	-21,304 Reduced 8.61%	226,181 $36.6 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $3.51 Million - $4.03 Million	26,169 Added 11.82%	247,485 $33.2 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $2.75 Million - $3.5 Million	-20,000 Reduced 8.29%	221,316 $33.9 Million
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $1.71 Million - $2.12 Million	-12,931 Reduced 5.09%	241,316 $39.1 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $1.49 Million - $1.89 Million	-13,896 Reduced 5.18%	254,247 $34.4 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $346,225 - $393,018	-3,254 Reduced 1.2%	268,143 $28.9 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $402,428 - $448,328	-3,825 Reduced 1.39%	271,397 $30.6 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $109,665 - $120,728	-1,072 Reduced 0.39%	275,222 $29.8 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $162,187 - $218,970	2,015 Added 0.73%	276,294 $29.6 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $3.91 Million - $4.59 Million	45,500 Added 19.89%	274,279 $24 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $15.1 Million - $20.2 Million	205,516 Added 883.45%	228,779 $22.5 Million
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $4.44 Million - $6.74 Million	-68,890 Reduced 74.76%	23,263 $1.77 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $1.3 Million - $1.63 Million	18,065 Added 24.38%	92,153 $8.16 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $3.62 Million - $4.36 Million	57,517 Added 347.09%	74,088 $5.61 Million
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $56,830 - $72,642	865 Added 5.51%	16,571 $1.21 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $50,141 - $59,013	-650 Reduced 3.97%	15,706 $1.27 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $79,484 - $98,026	-1,021 Reduced 5.88%	16,356 $1.51 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $30,051 - $33,407	-338 Reduced 1.91%	17,377 $1.64 Million
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $15,711 - $18,590	-175 Reduced 0.98%	17,715 $1.64 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $81,980 - $109,780	-891 Reduced 4.74%	17,890 $1.69 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $32,241 - $35,355	-360 Reduced 1.88%	18,781 $1.82 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $1.34 Million - $1.71 Million	19,141	19,141 $1.7 Million

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Philadelphia Trust CO with notifications on news.

Account

Philadelphia Trust CO Abb Vie Inc. Transaction History